ERCC1 Polymorphisms and Risk of Adult Glioma in a Chinese Population: A Hospital-Based Case-Control Study
Copyright policy )ERCC1 Polymorphisms and Risk of Adult Glioma in a Chinese Population: A Hospital-Based Case-Control Study
To examine the associations of two polymorphisms in excision repair cross-complementing rodent repair deficiency complementation group 1 (ERCC1) gene, C8092A (rs3212986) and T19007C (rs11615), with the risk of adult glioma, we performed a hospital-based case-control study with 257 new cases of glioma and 278 controls in Wenzhou, China. Results showed that polymorphisms C8092A and T19007C in ERCC1 gene were not associated with the risk of glioma in a Chinese population. Further studies in Chinese populations with larger sample sizes are still warranted.
- Sichuan University China (People's Republic of)
- Wenzhou Medical University China (People's Republic of)
Adult, Male, Risk, Polymorphism, Genetic, DNA Repair, Genotype, Brain Neoplasms, Glioma, Middle Aged, Endonucleases, DNA-Binding Proteins, Asian People, Case-Control Studies, Humans, Female
Adult, Male, Risk, Polymorphism, Genetic, DNA Repair, Genotype, Brain Neoplasms, Glioma, Middle Aged, Endonucleases, DNA-Binding Proteins, Asian People, Case-Control Studies, Humans, Female
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).20 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!